Patients
Specialty medication access hinges on a 48-hour window
The vast majority of healthcare providers (HCPs) say that PA-related delays directly harm patient outcomes.
Patients
Decline in overdose deaths ≠ The end of the opioid crisis
Since 2001, International Overdose Day has been observed as a moment to remember those lost to overdose and renew society’s commitment to
Market Access
Navigating Europe's AI regulatory labyrinth: A strategic gui...
For US drug developers, bringing AI tools across the Atlantic introduces steep regulatory hurdles.
R&D
Why the future of eSource starts with the research site
Capturing data digitally at source can significantly reduce the workflow for sites, yet, implementing it across studies has been rather unattainable.
Market Access
Biotech funding has returned. The bar has moved with it.
For biotech sponsors, the question worth asking is not whether the rebound is real, but what it is actually rewarding.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
